ID Biomedical Opens Channel For Fluviral Distribution in U.S.
Executive Summary
Henry Schein has committed to purchasing approximately half of all ID Biomedical Fluviral doses produced for the U.S. under a distribution agreement for the flu vaccine unveiled by the companies Dec. 6
You may also be interested in...
Chiron Negotiating Fluvirin Distribution Agreements For 2005 Flu Season
Chiron is confident it will reach distribution agreements for the influenza vaccine Fluvirin for the 2005-2006 season, CEO Howard Pien said
Chiron Negotiating Fluvirin Distribution Agreements For 2005 Flu Season
Chiron is confident it will reach distribution agreements for the influenza vaccine Fluvirin for the 2005-2006 season, CEO Howard Pien said
Fluvirin Status Uncertain Until March; 2005 Season Possible – Chiron
Chiron's Fluvirin manufacturing compliance issues are not likely to be resolved during the first quarter of 2005, but the company does expect to begin manufacturing in time to sell the flu vaccine for the 2005-2006 season